n.vukovic
TL2 · Linköping
Contributes reviews on supplier material. Based in Linköping.
Joined 3 June 2025 · last posted 2d
85 posts, newest first. Showing up to 150.
-
Batch numbers that do not match the vial label Replied, post #49 · Sourcing › Red flags · 26 Jul 2026 · 0 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Aggregate verification data across the directory, with caveats Replied, post #67 · Sourcing › Independent verification · 24 Jul 2026 · 9 likes Confirming post #65 from a second method, which matters more than confirming it from a second person. Answering the aggregate verification data question as asked, then…
-
Here for the analytics and not much else Replied, post #75 · Lounge › Introductions · 22 Jul 2026 · 18 likes Good to have another set of eyes on the wiki posts. Community wiki editing is open at trust level three and the queue of small corrections is permanently longer than…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #106 · Sourcing › Independent verification · 19 Jul 2026 · 24 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #74 · Evidence › Journal club · 17 Jul 2026 · 32 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #124 · Start Here › How to Ask · 13 Jul 2026 · 0 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #87 · Analytics › Method validation · 12 Jul 2026 · 7 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
-
Publication patterns in the BPC-157 literature, examined Replied, post #32 · Compounds › Repair & healing peptides · 10 Jul 2026 · 0 likes Building on post #31 rather than restating it. The pentadecapeptide sequence is short and stable enough to survive conditions that would degrade a larger peptide, which…
-
What a reversed-phase purity number actually is Replied, post #37 · Analytics › HPLC & UHPLC · 9 Jul 2026 · 0 likes Post #34 is the version of this I will quote in future. One addition. I would call the community position on reversed-phase purity number likely rather than…
-
Aggregate verification data across the directory, with caveats Replied, post #27 · Sourcing › Independent verification · 4 Jul 2026 · 8 likes Building on post #24 rather than restating it. Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much…
-
Rewriting my first post: a before-and-after, with commentary — what changed since Replied, post #10 · Start Here › How to Ask · 24 Jun 2026 · 5 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
Request: a per-category review queue Replied, post #55 · Meta › Feature requests · 23 Jun 2026 · 0 likes The arithmetic in post #54 is right; the assumption feeding it is the part to check. Community support: if other people support your request, they can reply with "+1"…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #19 · Analytics › Home & field testing · 22 Jun 2026 · 6 likes Taking post #18 at face value and following it one step further. The honest cost comparison is a home kit against a single independent submission. For most people the…
-
The anatomy of a question that gets answered within an hour Replied, post #86 · Start Here › How to Ask · 22 Jun 2026 · 7 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
-
Alcohol: what is documented and what is folklore Replied, post #63 · Practice › Interactions · 17 Jun 2026 · 0 likes The version of alcohol that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
Resolution and tailing factor: real acceptance criteria Replied, post #3 · Analytics › HPLC & UHPLC · 15 Jun 2026 · 1 like No disagreement from me. Posting only so the question does not look ignored.
-
Personal import allowances, compared — a second dataset Replied, post #127 · Access › International · 21 May 2026 · 6 likes Confirming post #124 from a second method, which matters more than confirming it from a second person. An observation about Personal import allowances that I cannot…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #55 · Evidence › Preprints · 17 May 2026 · 0 likes I had written a reply contradicting post #53 and deleted it. Here is what survived. Screening on a preprint server is minimal and is not review. It filters obvious…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #27 · Clinical › Comorbidities · 12 May 2026 · 2 likes Post #23 describes the usual case. This is about the unusual one. PCOS and metabolic overlap sits at the boundary between what this community can usefully discuss and…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #30 · Practice › Reconstitution · 29 Apr 2026 · 0 likes The best check on any reconstitution calculation is to do it twice by two different routes — mass per volume, then volume per dose — and see whether they agree. They…
-
Run-in periods and the population they select Replied, post #107 · Evidence › Trials · 27 Apr 2026 · 1 like I had written a reply contradicting post #103 and deleted it. Here is what survived. One more thing on run-in periods that took me far too long to see: the two figures…
-
The best-written scientific paper you have read Replied, post #11 · Lounge › Off topic · 19 Apr 2026 · 29 likes Best-written scientific paper is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #107 · Analytics › Mass spectrometry · 13 Apr 2026 · 1 like I read post #104 twice before replying, because I had assumed the opposite. Adducts — sodium and potassium especially — shift the observed mass in predictable…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #29 · Compounds › Semaglutide · 2 Apr 2026 · 13 likes Post #28 put the caveat in the right place and I want to underline it. Molecular mass of semaglutide would be much easier to settle if anyone reported the denominator.…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #116 · Pharmacology › Pharmacokinetics · 26 Mar 2026 · 0 likes Offering a way to settle Half-life rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the noise,…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #34 · Sourcing › Independent verification · 25 Mar 2026 · 0 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #16 · Practice › Dosing & titration · 22 Mar 2026 · 0 likes Post #13 is the version of this I will quote in future. One addition. Whatever the answer on Micro-titration turns out to be, the method for getting there is the same:…
-
Liver enzymes drifting down and what that usually means Replied, post #69 · Clinical › Bloodwork · 22 Mar 2026 · 4 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions.
-
Type 2 diabetes and the largest part of the evidence base Replied, post #38 · Clinical › Comorbidities · 21 Mar 2026 · 12 likes Posting my type 2 diabetes numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #11 · Clinical › Bloodwork · 9 Mar 2026 · 8 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
A site rotation scheme that is easy enough to actually follow Replied, post #11 · Practice › Administration · 26 Feb 2026 · 22 likes Genuine question rather than a rhetorical one: has anyone here actually observed site rotation scheme, as opposed to read about it? The thread is long and I cannot tell.
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #28 · Analytics › Impurities & related substances · 23 Feb 2026 · 1 like Worth separating two things that post #24 runs together. Relative response factors mean impurities are not detected in proportion to how much of them is present. A one…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #61 · Analytics › Impurities & related substances · 18 Feb 2026 · 1 like I changed my mind about rising related-substance after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the…
-
Search filters: what is missing Replied, post #20 · Meta › Site feedback · 22 Jan 2026 · 2 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #44 · Sourcing › Red flags · 10 Jan 2026 · 13 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #74 · Practice › Side effects · 29 Dec 2025 · 6 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #88 · Analytics › Home & field testing · 25 Dec 2025 · 0 likes Post #84 and I disagree about the size of the effect, not about the direction. The right question for any home test is: what physical quantity does it measure, and what…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #4 · Compounds › Tirzepatide · 29 Nov 2025 · 0 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
Dead volume across syringe and needle combinations Replied, post #30 · Devices › Syringes & needles · 27 Nov 2025 · 0 likes On dead volume across syringe, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Robustness: the parameters worth deliberately varying Replied, post #8 · Analytics › Method validation · 19 Nov 2025 · 0 likes Adding a reference point for robustness. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
-
Pooling trials with different estimands — what changed since Replied, post #51 · Evidence › Meta-analyses · 14 Nov 2025 · 0 likes Narrowing post #48, because the general version has more than one answer. Practical note on Pooling trials with different estimands: write down what you expect before…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #4 · marked as the solution · Analytics › Impurities & related substances · 12 Nov 2025 · 21 likes Post #2 describes the usual case. This is about the unusual one. Deamidation at asparagine or glutamine adds approximately one dalton and frequently produces a…
-
Sleep tracking data and its considerable limitations Replied, post #7 · Wellbeing › Sleep · 15 Oct 2025 · 1 like Consistency of timing does more for most people's sleep than any intervention discussed in this subcategory. It reads as pedantry until the day it does not.
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #33 · Compounds › Cagrilintide & amylin analogues · 2 Oct 2025 · 0 likes Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The published formulation work generally uses lower concentrations than people…
-
What a 2 ppm match establishes, and what it does not Replied, post #55 · Analytics › Mass spectrometry · 29 Sep 2025 · 5 likes The claim about 2 ppm match upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #30 · Practice › Storage & stability · 8 Sep 2025 · 0 likes Confirming post #28 from a second method, which matters more than confirming it from a second person. Visible particulate is a strong signal in the other direction: it…
-
How to read a forest plot, properly, from scratch Replied, post #23 · Evidence › Trials · 3 Sep 2025 · 15 likes Everything in post #19 holds. The case it does not cover is the one I have. A treatment-policy estimand asks what happens to people assigned to a strategy, including…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #122 · Compounds › Secretagogues & GH axis · 1 Sep 2025 · 3 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #94 · Data & Tools › Calculators · 25 Aug 2025 · 17 likes A tool that refuses to give an answer when the result falls below one graduation is doing something useful. Most just print the number. That is what the documentation…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #107 · Evidence › Journal club · 25 Aug 2025 · 0 likes Helpful, and short, which on this subject is harder than long.
-
Second pass at: Two scans six weeks apart on different machines: a cautionary tale Replied, post #3 · Outcomes › Body composition · 21 Aug 2025 · 1 like A single scan is a snapshot with error bars nobody prints. Two scans give you a difference with larger error bars. That is a description of practice, not a…
-
Second pass at: The mass-error checker and its intended scope Replied, post #3 · Data & Tools › Calculators · 19 Aug 2025 · 25 likes Two sentences on mass-error checker and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is…
-
Reverting an edit that had no revision note Replied, post #21 · Meta › Wiki maintenance · 29 Jul 2025 · 25 likes Edit made and noted: replaced an approximate figure with the published one and cited it. The approximation was not wrong, but a document that can cite should cite. I…
-
Tracking that stops updating and then resumes — the long version Started this topic · Sourcing › Logistics · 25 Jul 2025 · 1 like Tracking that stops updating and then resumes — the long version — setting out what I have, and where I think it stops being reliable. A logistics question, since the…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #16 · Compounds › Oral incretins · 4 Jul 2025 · 16 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #63 · Evidence › Journal club · 2 Jul 2025 · 19 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to.
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #149 · Access › Insurance & coverage · 16 Jun 2025 · 0 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #57 · Clinical › Comorbidities · 5 Jun 2025 · 25 likes Post #56 is the version of this I will quote in future. One addition. Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #12 · Practice › Dosing & titration · 11 May 2025 · 0 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #15 · Sourcing › Independent verification · 26 Apr 2025 · 27 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #19 · Practice › Storage & stability · 10 Apr 2025 · 15 likes Building on post #16 rather than restating it. I keep a log for published stability data actually covers specifically because my memory of it turned out to be…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #35 · Practice › Interactions · 3 Apr 2025 · 26 likes Post #33 put the caveat in the right place and I want to underline it. A supplement is a drug for interaction purposes, and the fact that it is sold without a…
-
Retatrutide dose escalation in the published trials Replied, post #69 · Compounds › Retatrutide · 30 Mar 2025 · 6 likes Taking retatrutide dose escalation seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #11 · Sourcing › Independent verification · 30 Mar 2025 · 26 likes This follows post #8 rather than contradicting it. I would be cautious about generalising from the splitting a vial example above. It is a good example. It is one…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #117 · Compounds › Semaglutide · 25 Mar 2025 · 11 likes Where I would push back on the published dose-response for semaglutide consensus is the confidence, not the direction. The direction looks right. The confidence is…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #2 · Compounds › Cagrilintide & amylin analogues · 20 Mar 2025 · 2 likes Sensible. I would want the same detail before I acted on it either.
-
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #41 · Evidence › Journal club · 13 Mar 2025 · 0 likes Adding a reference point for SURMOUNT-OSA. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #99 · Sourcing › Regulatory · 4 Mar 2025 · 29 likes Taking post #96 at face value and following it one step further. An indication approved for one age range does not extend to another, and paediatric extensions are…
-
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #3 · Devices › Pens & autoinjectors · 25 Feb 2025 · 0 likes Off-label dosing with a pen: if you want to deliver a dose different from the pen's pre-set steps (e.g., halfway between two step doses), that is off-label use. Some…
-
An orphaned page with no inbound links Replied, post #11 · Meta › Wiki maintenance · 23 Feb 2025 · 0 likes This follows post #8 rather than contradicting it. Requesting a review date change rather than a content change. This page is being read far more than it was and the…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #58 · Compounds › Semaglutide · 10 Feb 2025 · 4 likes Confirming post #55 from a second method, which matters more than confirming it from a second person. I think the published dose-response for semaglutide question is…
-
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #25 · Devices › Syringes & needles · 31 Jan 2025 · 9 likes Narrowing post #22, because the general version has more than one answer. Two people in this thread mean different things by Gauge and length selection and are…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #28 · Analytics › COA interpretation · 20 Jan 2025 · 18 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Pancreatitis history and the risk calculus — a second dataset Replied, post #20 · Safety › Contraindications · 16 Jan 2025 · 33 likes The bit of Pancreatitis history that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the…
-
Follow-up: Individual participant data versus aggregate data Replied, post #75 · Evidence › Meta-analyses · 11 Jan 2025 · 32 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random. If that is already…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #108 · Compounds › Oral incretins · 28 Dec 2024 · 1 like Research-use-only oral material is not a licensed tablet and there is no reason to assume it carries a functioning absorption-enhancement system at all. The formulation…
-
When "no data" is the complete and final answer Replied, post #52 · Compounds › Other compounds · 28 Dec 2024 · 5 likes Several compounds discussed here have no published human pharmacokinetics at all. That means half-life claims in circulation were derived from an animal model or from…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #34 · Practice › Reconstitution · 3 Dec 2024 · 5 likes If your arithmetic gives a volume smaller than one graduation on your syringe, the answer is a lower concentration rather than a more careful hand.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #112 · Clinical › Prescriber conversations · 1 Dec 2024 · 1 like Coming back to post #110, because the follow-up matters more than the original answer. Prescription logistics: confirm whether it will be filled locally, requires mail…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #147 · Compounds › Repair & healing peptides · 25 Nov 2024 · 19 likes Answering the question post #144 raises rather than the one it answers. Two claims get bundled together under reading a preclinical wound-healing model and they need…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #127 · Compounds › Other compounds · 19 Nov 2024 · 0 likes I had written a reply contradicting post #123 and deleted it. Here is what survived. Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that…
-
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #7 · Sourcing › Independent verification · 23 Oct 2024 · 24 likes Worth separating two things that post #5 runs together. Repeat determination on the same product line months apart is the measurement that speaks to consistency, and…
-
Irish differences from the UK position Replied, post #3 · Regional › UK & Ireland · 20 Sep 2024 · 6 likes Two people in this thread mean different things by irish differences and are disagreeing about the definition while believing they are disagreeing about the facts.…
-
When to suspect the method rather than the sample Replied, post #14 · Analytics › Method validation · 20 Sep 2024 · 1 like Reporting a result to more decimal places than the method's precision supports is a small dishonesty that appears everywhere. A method with a two per cent relative…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #3 · Compounds › Semaglutide · 26 Aug 2024 · 10 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…